Orbis Investment Management (US)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$8.81M Buy
137,538
+51,125
+59% +$3.77M 8.84% 3
2018
Q3
$7.73M Hold
86,413
5.59% 5
2018
Q2
$6.86M Buy
86,413
+27,652
+47% +$2.3M 5.19% 7
2018
Q1
$5.24M Buy
58,761
+34,482
+142% +$3.31M 3.65% 13
2017
Q4
$2.53M Buy
+24,279
New +$2.74M 1.72% 18
2017
Q2
Sell
-35,488
Closed -$4.42M 25
2017
Q1
$4.42M Sell
35,488
-11,824
-25% -$1.41M 3.08% 15
2016
Q4
$5.48M Buy
47,312
+4,899
+12% +$546K 3.93% 13
2016
Q3
$4.43M Sell
42,413
-9,594
-18% -$1.04M 3.15% 16
2016
Q2
$5.13M Hold
52,007
4.31% 9
2016
Q1
$5.21M Buy
52,007
+14,404
+38% +$1.48M 4.49% 9
2015
Q4
$4.5M Buy
37,603
+7,278
+24% +$842K 3.87% 15
2015
Q3
$3.28M Sell
30,325
-3,294
-10% -$409K 2.97% 15
2015
Q2
$3.89M Sell
33,619
-6,820
-17% -$780K 3.14% 14
2015
Q1
$4.66M Sell
40,439
-9,225
-19% -$1.1M 3.83% 13
2014
Q4
$5.55M Sell
49,664
-8,090
-14% -$853K 4.6% 10
2014
Q3
$5.47M Hold
57,754
4.55% 9
2014
Q2
$4.96M Buy
+57,754
New +$4.39M 4.11% 10

Other funds holding CELG

Orbis Investment Management (US)'s CELG Position: Q4 2018 in Review

Orbis Investment Management (US) increased its Celgene Corp (CELG) stake by 59% in Q4 2018, buying an estimated $3.77M and bringing the position to 137,538 shares worth $8.81M. The position accounts for 8.84% of the portfolio, ranked #3.

Orbis Investment Management (US) first reported a position in CELG in Q2 2014 and has held it in 17 quarters since. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Orbis Investment Management (US) held 137,538 shares of Celgene Corp worth $8.81M as of Q4 2018.
  • Orbis Investment Management (US) bought 51,125 Celgene Corp shares in Q4 2018, an estimated $3.77M.
  • Celgene Corp made up 8.84% of Orbis Investment Management (US)'s portfolio in Q4 2018, its #3 holding.
  • Orbis Investment Management (US) first reported a position in Celgene Corp in Q2 2014 and has held it in 17 quarters since.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Orbis Investment Management (US)'s 13F filing for Q4 2018, filed 14 Feb 2019.